Oddity price target lowered to $44 from $46 at Barclays

Barclays lowered the firm’s price target on Oddity to $44 from $46 and keeps an Equal Weight rating on the shares ahead of the Q1 report. In consumer health products and beverages, investors are starting to look beyond the expensive high-visibility names for more value-oriented opportunities, the analyst tells investors in a research note. Meanwhile, in food, the firm wouldn’t be surprised to see more “second derivative” share reactions to Q1 upside versus “admittedly very subdued expectations.”